

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | adaptation of signaling pathway (GO:0023058) | 6.64236788 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.49297022 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 5.33730260 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.20810005 |
| 5 | vocalization behavior (GO:0071625) | 5.16102893 |
| 6 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.00094404 |
| 7 | positive regulation of action potential (GO:0045760) | 4.90246188 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.76804972 |
| 9 | neuron remodeling (GO:0016322) | 4.72353434 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.68060012 |
| 11 | protein localization to synapse (GO:0035418) | 4.49802144 |
| 12 | sympathetic nervous system development (GO:0048485) | 4.41760227 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.35958304 |
| 14 | nucleobase catabolic process (GO:0046113) | 4.35786299 |
| 15 | regulation of respiratory system process (GO:0044065) | 4.26411646 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.13657027 |
| 17 | proline transport (GO:0015824) | 4.12868897 |
| 18 | neuron recognition (GO:0008038) | 4.09556248 |
| 19 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.09182489 |
| 20 | retina layer formation (GO:0010842) | 4.07928761 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.07885201 |
| 22 | opioid receptor signaling pathway (GO:0038003) | 4.02817321 |
| 23 | neurofilament cytoskeleton organization (GO:0060052) | 4.01407521 |
| 24 | neurotransmitter catabolic process (GO:0042135) | 3.97551319 |
| 25 | synaptic vesicle maturation (GO:0016188) | 3.96495756 |
| 26 | regulation of respiratory gaseous exchange (GO:0043576) | 3.93837236 |
| 27 | locomotory exploration behavior (GO:0035641) | 3.93365062 |
| 28 | establishment of mitochondrion localization (GO:0051654) | 3.92320114 |
| 29 | mating behavior (GO:0007617) | 3.88979609 |
| 30 | glutamate secretion (GO:0014047) | 3.84548957 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.84440705 |
| 32 | layer formation in cerebral cortex (GO:0021819) | 3.81735662 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.78157191 |
| 34 | ganglion development (GO:0061548) | 3.75803184 |
| 35 | neurotransmitter transport (GO:0006836) | 3.73236032 |
| 36 | dopamine receptor signaling pathway (GO:0007212) | 3.71001349 |
| 37 | cell differentiation in hindbrain (GO:0021533) | 3.70794503 |
| 38 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.69833575 |
| 39 | exploration behavior (GO:0035640) | 3.69516155 |
| 40 | regulation of synaptic vesicle transport (GO:1902803) | 3.66668634 |
| 41 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.66322112 |
| 42 | regulation of glutamate secretion (GO:0014048) | 3.65733822 |
| 43 | transmission of nerve impulse (GO:0019226) | 3.64049740 |
| 44 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.63543184 |
| 45 | mitochondrion transport along microtubule (GO:0047497) | 3.58765989 |
| 46 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.58765989 |
| 47 | neuron maturation (GO:0042551) | 3.58537411 |
| 48 | axonal fasciculation (GO:0007413) | 3.54122498 |
| 49 | regulation of microtubule-based movement (GO:0060632) | 3.53509440 |
| 50 | positive regulation of synapse assembly (GO:0051965) | 3.52550487 |
| 51 | dopamine biosynthetic process (GO:0042416) | 3.51998350 |
| 52 | synaptic transmission, cholinergic (GO:0007271) | 3.51844224 |
| 53 | phenol-containing compound catabolic process (GO:0019336) | 3.50720556 |
| 54 | dendritic spine morphogenesis (GO:0060997) | 3.48586780 |
| 55 | regulation of neurotransmitter levels (GO:0001505) | 3.45566575 |
| 56 | catecholamine transport (GO:0051937) | 3.45301100 |
| 57 | auditory behavior (GO:0031223) | 3.40727680 |
| 58 | negative regulation of microtubule polymerization (GO:0031115) | 3.40525223 |
| 59 | regulation of vesicle fusion (GO:0031338) | 3.36954452 |
| 60 | maternal behavior (GO:0042711) | 3.36789459 |
| 61 | cell migration in hindbrain (GO:0021535) | 3.35601118 |
| 62 | negative regulation of heart rate (GO:0010459) | 3.35556958 |
| 63 | gamma-aminobutyric acid transport (GO:0015812) | 3.34006213 |
| 64 | neuronal action potential propagation (GO:0019227) | 3.33918078 |
| 65 | synapse assembly (GO:0007416) | 3.32571067 |
| 66 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.31349074 |
| 67 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.31325475 |
| 68 | potassium ion homeostasis (GO:0055075) | 3.30914293 |
| 69 | glutamate receptor signaling pathway (GO:0007215) | 3.29635758 |
| 70 | sensory perception of pain (GO:0019233) | 3.26740523 |
| 71 | neuron-neuron synaptic transmission (GO:0007270) | 3.24381215 |
| 72 | neuronal ion channel clustering (GO:0045161) | 3.24244558 |
| 73 | social behavior (GO:0035176) | 3.23697336 |
| 74 | intraspecies interaction between organisms (GO:0051703) | 3.23697336 |
| 75 | response to auditory stimulus (GO:0010996) | 3.23421636 |
| 76 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.22618122 |
| 77 | activation of protein kinase A activity (GO:0034199) | 3.22153689 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.21917407 |
| 79 | protein polyglutamylation (GO:0018095) | 3.20990781 |
| 80 | dopaminergic neuron differentiation (GO:0071542) | 3.19893010 |
| 81 | regulation of action potential (GO:0098900) | 3.15870196 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 3.15074868 |
| 83 | postsynaptic membrane organization (GO:0001941) | 3.15002762 |
| 84 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.14377065 |
| 85 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.13258025 |
| 86 | behavioral response to nicotine (GO:0035095) | 3.12789568 |
| 87 | multi-organism reproductive behavior (GO:0044705) | 3.10976112 |
| 88 | synaptic transmission, glutamatergic (GO:0035249) | 3.10835271 |
| 89 | regulation of protein kinase A signaling (GO:0010738) | 3.10689152 |
| 90 | response to histamine (GO:0034776) | 3.09347690 |
| 91 | female mating behavior (GO:0060180) | 3.07466729 |
| 92 | presynaptic membrane assembly (GO:0097105) | 3.04611121 |
| 93 | adult walking behavior (GO:0007628) | 3.04006308 |
| 94 | regulation of dopamine secretion (GO:0014059) | 3.03285560 |
| 95 | regulation of synapse structural plasticity (GO:0051823) | 3.02543961 |
| 96 | positive regulation of amino acid transport (GO:0051957) | 3.02176395 |
| 97 | positive regulation of filopodium assembly (GO:0051491) | 3.00718221 |
| 98 | long-term memory (GO:0007616) | 3.00705436 |
| 99 | synaptic vesicle endocytosis (GO:0048488) | 2.98646262 |
| 100 | regulation of neurotransmitter secretion (GO:0046928) | 2.97490867 |
| 101 | reproductive behavior (GO:0019098) | 2.96129838 |
| 102 | membrane depolarization during action potential (GO:0086010) | 2.95739469 |
| 103 | detection of calcium ion (GO:0005513) | 2.94844509 |
| 104 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193) | 2.94168222 |
| 105 | neuronal action potential (GO:0019228) | 2.93112776 |
| 106 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.93093612 |
| 107 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.92847479 |
| 108 | response to pheromone (GO:0019236) | 2.92819523 |
| 109 | behavioral response to ethanol (GO:0048149) | 2.91888554 |
| 110 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.91204593 |
| 111 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.91136903 |
| 112 | neurotransmitter biosynthetic process (GO:0042136) | 2.89542951 |
| 113 | parental behavior (GO:0060746) | 2.89054253 |
| 114 | regulation of postsynaptic membrane potential (GO:0060078) | 2.88373851 |
| 115 | regulation of synapse assembly (GO:0051963) | 2.88311967 |
| 116 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.88094766 |
| 117 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.87312061 |
| 118 | presynaptic membrane organization (GO:0097090) | 2.86940589 |
| 119 | regulation of neurotransmitter transport (GO:0051588) | 2.86922554 |
| 120 | synaptic vesicle transport (GO:0048489) | 2.86767216 |
| 121 | establishment of synaptic vesicle localization (GO:0097480) | 2.86767216 |
| 122 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.86584366 |
| 123 | dopamine transport (GO:0015872) | 2.85381223 |
| 124 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.84478216 |
| 125 | response to dietary excess (GO:0002021) | 2.83599634 |
| 126 | membrane hyperpolarization (GO:0060081) | 2.82442104 |
| 127 | prepulse inhibition (GO:0060134) | 2.82134929 |
| 128 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.81951931 |
| 129 | dendrite morphogenesis (GO:0048813) | 2.81501044 |
| 130 | cerebellar granule cell differentiation (GO:0021707) | 2.81433347 |
| 131 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.81378984 |
| 132 | neuromuscular synaptic transmission (GO:0007274) | 2.81127409 |
| 133 | synaptic transmission (GO:0007268) | 2.80908046 |
| 134 | synapse organization (GO:0050808) | 2.79523159 |
| 135 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.79395740 |
| 136 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.79219951 |
| 137 | membrane depolarization (GO:0051899) | 2.79085435 |
| 138 | fear response (GO:0042596) | 2.78895899 |
| 139 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.78115750 |
| 140 | mechanosensory behavior (GO:0007638) | 2.75486971 |
| 141 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.73378360 |
| 142 | DNA methylation involved in gamete generation (GO:0043046) | 2.73365198 |
| 143 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.73227982 |
| 144 | glycosphingolipid biosynthetic process (GO:0006688) | 2.72939628 |
| 145 | negative regulation of cell cycle arrest (GO:0071157) | 2.71965511 |
| 146 | response to nicotine (GO:0035094) | 2.70261379 |
| 147 | regulation of filopodium assembly (GO:0051489) | 2.69077036 |
| 148 | central nervous system neuron axonogenesis (GO:0021955) | 2.68949890 |
| 149 | membrane repolarization (GO:0086009) | 2.67415906 |
| 150 | positive regulation of synapse maturation (GO:0090129) | 2.67227558 |
| 151 | positive regulation of vesicle fusion (GO:0031340) | 2.66537240 |
| 152 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.63995787 |
| 153 | adult behavior (GO:0030534) | 2.61539148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.64101834 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.32773368 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.08961339 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96554519 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94828667 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.72501647 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.65415252 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59814429 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58954895 |
| 10 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.58422054 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55926180 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53656997 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.51718372 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50949191 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50949191 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43577884 |
| 17 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.41039005 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38712545 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34944670 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.23051159 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19715452 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.17405268 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.16385035 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15681327 |
| 25 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.12479653 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07160603 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.02286160 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02254603 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00266914 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89135566 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84897547 |
| 32 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.81577165 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.74084134 |
| 34 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.74042164 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69912056 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.69404258 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66616179 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63667299 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.61713405 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59965493 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.59115697 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.58467741 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.58178206 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.58085694 |
| 45 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.55970512 |
| 46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52899181 |
| 47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.47570521 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41784714 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38784576 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37904621 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36424414 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.35071143 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33680489 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32807558 |
| 55 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32508803 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30754016 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29311245 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27276299 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27270789 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27135815 |
| 61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26937888 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26610897 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26136255 |
| 64 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.22390874 |
| 65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19830333 |
| 66 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19548925 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18831855 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17061594 |
| 69 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15137173 |
| 70 | JUN_21703547_ChIP-Seq_K562_Human | 1.15068875 |
| 71 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13447571 |
| 72 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10362208 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09816317 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08239962 |
| 75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08181793 |
| 76 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07847618 |
| 77 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.04669455 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04204103 |
| 79 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03072441 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01811097 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01683687 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00247585 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99570973 |
| 84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99486750 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.99229954 |
| 86 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98881586 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98739811 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98238124 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97934335 |
| 90 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95977290 |
| 91 | AR_19668381_ChIP-Seq_PC3_Human | 0.95918339 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95651001 |
| 93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94769103 |
| 94 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94674690 |
| 95 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94520905 |
| 96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94340457 |
| 97 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94088355 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93723188 |
| 99 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93705510 |
| 100 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.93591363 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92831981 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91693712 |
| 103 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90285010 |
| 104 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89997056 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89786885 |
| 106 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89429276 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89273748 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88675287 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88675287 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88524032 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87983616 |
| 112 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.84488779 |
| 113 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.84446187 |
| 114 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.83928618 |
| 115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.82858020 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82457744 |
| 117 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82116467 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82116467 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81942059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.12674375 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.06222049 |
| 3 | MP0006276_abnormal_autonomic_nervous | 3.75305662 |
| 4 | MP0002822_catalepsy | 3.56506718 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.37119270 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.23081418 |
| 7 | MP0004270_analgesia | 3.10963530 |
| 8 | MP0009745_abnormal_behavioral_response | 3.04825232 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.80835546 |
| 10 | MP0003122_maternal_imprinting | 2.80690797 |
| 11 | MP0001529_abnormal_vocalization | 2.74862524 |
| 12 | MP0002064_seizures | 2.73763155 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.72803807 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.71521664 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.71406780 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.63511935 |
| 17 | MP0009046_muscle_twitch | 2.60393493 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.58248744 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.51240735 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.50072096 |
| 21 | MP0002736_abnormal_nociception_after | 2.48887956 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 2.47528090 |
| 23 | MP0002272_abnormal_nervous_system | 2.29001226 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.28445957 |
| 25 | MP0001905_abnormal_dopamine_level | 2.28247500 |
| 26 | MP0001970_abnormal_pain_threshold | 2.23663838 |
| 27 | MP0002184_abnormal_innervation | 1.99923053 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.97547466 |
| 29 | MP0004924_abnormal_behavior | 1.97547466 |
| 30 | MP0001486_abnormal_startle_reflex | 1.96939291 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.91908683 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.90337431 |
| 33 | MP0000778_abnormal_nervous_system | 1.88045809 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.79824432 |
| 35 | MP0004858_abnormal_nervous_system | 1.74649234 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.73673297 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.69382011 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.67541397 |
| 39 | MP0003136_yellow_coat_color | 1.65933460 |
| 40 | MP0001188_hyperpigmentation | 1.62675330 |
| 41 | MP0001984_abnormal_olfaction | 1.60774975 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.60632819 |
| 43 | MP0004142_abnormal_muscle_tone | 1.57507414 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.52122072 |
| 45 | MP0003646_muscle_fatigue | 1.45607238 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.42781290 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.42063561 |
| 48 | MP0004130_abnormal_muscle_cell | 1.40185055 |
| 49 | MP0003329_amyloid_beta_deposits | 1.37480700 |
| 50 | MP0000955_abnormal_spinal_cord | 1.35419439 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.30944135 |
| 52 | MP0003787_abnormal_imprinting | 1.29875036 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.28426624 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.28325259 |
| 55 | MP0000751_myopathy | 1.26540245 |
| 56 | MP0003121_genomic_imprinting | 1.22014850 |
| 57 | MP0005171_absent_coat_pigmentation | 1.19343136 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.18945029 |
| 59 | MP0002751_abnormal_autonomic_nervous | 1.18039926 |
| 60 | MP0008569_lethality_at_weaning | 1.17443518 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 1.16598083 |
| 62 | MP0008872_abnormal_physiological_respon | 1.15070421 |
| 63 | MP0000538_abnormal_urinary_bladder | 1.10791723 |
| 64 | MP0004133_heterotaxia | 1.10222541 |
| 65 | MP0002928_abnormal_bile_duct | 1.06865720 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 1.05241266 |
| 67 | MP0005535_abnormal_body_temperature | 1.03826020 |
| 68 | MP0009379_abnormal_foot_pigmentation | 1.02190807 |
| 69 | MP0003283_abnormal_digestive_organ | 1.02090588 |
| 70 | MP0004742_abnormal_vestibular_system | 1.00815229 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.99381038 |
| 72 | MP0002152_abnormal_brain_morphology | 0.98979215 |
| 73 | MP0005377_hearing/vestibular/ear_phenot | 0.98966445 |
| 74 | MP0003878_abnormal_ear_physiology | 0.98966445 |
| 75 | MP0002069_abnormal_eating/drinking_beha | 0.98132394 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.97161890 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.96816843 |
| 78 | MP0003879_abnormal_hair_cell | 0.93980173 |
| 79 | MP0003633_abnormal_nervous_system | 0.93890742 |
| 80 | MP0002163_abnormal_gland_morphology | 0.92730669 |
| 81 | MP0001324_abnormal_eye_pigmentation | 0.92421323 |
| 82 | MP0005551_abnormal_eye_electrophysiolog | 0.92254818 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.90898067 |
| 84 | MP0002229_neurodegeneration | 0.90510826 |
| 85 | MP0003123_paternal_imprinting | 0.90465525 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 0.90258571 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.86423755 |
| 88 | MP0003631_nervous_system_phenotype | 0.82847487 |
| 89 | MP0004085_abnormal_heartbeat | 0.80259430 |
| 90 | MP0005195_abnormal_posterior_eye | 0.79552856 |
| 91 | MP0004885_abnormal_endolymph | 0.78328811 |
| 92 | MP0005394_taste/olfaction_phenotype | 0.78318990 |
| 93 | MP0005499_abnormal_olfactory_system | 0.78318990 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.76380557 |
| 95 | MP0001963_abnormal_hearing_physiology | 0.75791559 |
| 96 | MP0001664_abnormal_digestion | 0.75712515 |
| 97 | MP0002102_abnormal_ear_morphology | 0.74616721 |
| 98 | MP0000569_abnormal_digit_pigmentation | 0.73554585 |
| 99 | MP0005409_darkened_coat_color | 0.72167371 |
| 100 | MP0003634_abnormal_glial_cell | 0.71014144 |
| 101 | MP0005174_abnormal_tail_pigmentation | 0.66115787 |
| 102 | MP0001177_atelectasis | 0.64894138 |
| 103 | MP0000604_amyloidosis | 0.64827818 |
| 104 | MP0008874_decreased_physiological_sensi | 0.63916888 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.62707614 |
| 106 | MP0003011_delayed_dark_adaptation | 0.62129568 |
| 107 | MP0001943_abnormal_respiration | 0.61136188 |
| 108 | MP0005253_abnormal_eye_physiology | 0.60703707 |
| 109 | MP0000026_abnormal_inner_ear | 0.55555401 |
| 110 | MP0006292_abnormal_olfactory_placode | 0.55521243 |
| 111 | MP0000681_abnormal_thyroid_gland | 0.55211499 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.54799077 |
| 113 | MP0005448_abnormal_energy_balance | 0.54451723 |
| 114 | MP0003632_abnormal_nervous_system | 0.54290407 |
| 115 | MP0002160_abnormal_reproductive_system | 0.54185986 |
| 116 | MP0002090_abnormal_vision | 0.53802852 |
| 117 | MP0000747_muscle_weakness | 0.52780521 |
| 118 | MP0003861_abnormal_nervous_system | 0.50826290 |
| 119 | MP0002332_abnormal_exercise_endurance | 0.50238234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.56729994 |
| 2 | Myokymia (HP:0002411) | 5.77138561 |
| 3 | Retinal atrophy (HP:0001105) | 5.44295235 |
| 4 | Limb dystonia (HP:0002451) | 5.22758053 |
| 5 | Focal seizures (HP:0007359) | 5.05077220 |
| 6 | Hypothermia (HP:0002045) | 5.00628982 |
| 7 | Visual hallucinations (HP:0002367) | 4.80363772 |
| 8 | Atonic seizures (HP:0010819) | 4.79557010 |
| 9 | Febrile seizures (HP:0002373) | 4.10764978 |
| 10 | Absence seizures (HP:0002121) | 4.06242140 |
| 11 | Polyphagia (HP:0002591) | 3.70768228 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.68415480 |
| 13 | Dialeptic seizures (HP:0011146) | 3.67267700 |
| 14 | Failure to thrive in infancy (HP:0001531) | 3.65439698 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.59496141 |
| 16 | Epileptic encephalopathy (HP:0200134) | 3.55666168 |
| 17 | Shawl scrotum (HP:0000049) | 3.40479907 |
| 18 | Pheochromocytoma (HP:0002666) | 3.18851819 |
| 19 | Nephronophthisis (HP:0000090) | 3.12435001 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.11740165 |
| 21 | Progressive inability to walk (HP:0002505) | 3.08868705 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.08686101 |
| 23 | Amblyopia (HP:0000646) | 3.08633178 |
| 24 | Abnormal hair whorl (HP:0010721) | 3.05794627 |
| 25 | Thyroid-stimulating hormone excess (HP:0002925) | 3.01692437 |
| 26 | Genetic anticipation (HP:0003743) | 2.99884248 |
| 27 | Agitation (HP:0000713) | 2.95076076 |
| 28 | Neuroendocrine neoplasm (HP:0100634) | 2.91729694 |
| 29 | Poor suck (HP:0002033) | 2.89157575 |
| 30 | Hypoventilation (HP:0002791) | 2.88847660 |
| 31 | Gait imbalance (HP:0002141) | 2.82257361 |
| 32 | Broad-based gait (HP:0002136) | 2.74545984 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.72601645 |
| 34 | Mutism (HP:0002300) | 2.70597241 |
| 35 | Anxiety (HP:0000739) | 2.70479459 |
| 36 | Ankle clonus (HP:0011448) | 2.70283246 |
| 37 | Parakeratosis (HP:0001036) | 2.65464394 |
| 38 | High anterior hairline (HP:0009890) | 2.61393032 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.57479155 |
| 40 | Diplopia (HP:0000651) | 2.57479155 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 2.56607687 |
| 42 | Hyperventilation (HP:0002883) | 2.55836706 |
| 43 | Hyperthyroidism (HP:0000836) | 2.50275705 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.49008690 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.49008690 |
| 46 | Pancreatic cysts (HP:0001737) | 2.48756654 |
| 47 | Lissencephaly (HP:0001339) | 2.45665958 |
| 48 | Pachygyria (HP:0001302) | 2.44020594 |
| 49 | Action tremor (HP:0002345) | 2.43868269 |
| 50 | Craniofacial dystonia (HP:0012179) | 2.43562971 |
| 51 | Excessive salivation (HP:0003781) | 2.42381931 |
| 52 | Drooling (HP:0002307) | 2.42381931 |
| 53 | Myotonia (HP:0002486) | 2.42099939 |
| 54 | Abnormality of the corticospinal tract (HP:0002492) | 2.40493242 |
| 55 | Abnormality of the renal medulla (HP:0100957) | 2.40040231 |
| 56 | Esotropia (HP:0000565) | 2.39303443 |
| 57 | Progressive macrocephaly (HP:0004481) | 2.36785848 |
| 58 | Medial flaring of the eyebrow (HP:0010747) | 2.36683398 |
| 59 | Abnormal ciliary motility (HP:0012262) | 2.36437244 |
| 60 | Truncal ataxia (HP:0002078) | 2.35736622 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 2.35631494 |
| 62 | Protruding tongue (HP:0010808) | 2.34699834 |
| 63 | Depression (HP:0000716) | 2.34034143 |
| 64 | Congenital primary aphakia (HP:0007707) | 2.32840113 |
| 65 | Oligomenorrhea (HP:0000876) | 2.32449469 |
| 66 | Termporal pattern (HP:0011008) | 2.32089740 |
| 67 | Insidious onset (HP:0003587) | 2.32089740 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.31575658 |
| 69 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.29373914 |
| 70 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.27721592 |
| 71 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.26834044 |
| 72 | Poor eye contact (HP:0000817) | 2.26525729 |
| 73 | Spastic tetraplegia (HP:0002510) | 2.26379265 |
| 74 | Inappropriate behavior (HP:0000719) | 2.25879701 |
| 75 | Papilledema (HP:0001085) | 2.25157218 |
| 76 | Genital tract atresia (HP:0001827) | 2.24975626 |
| 77 | Psychosis (HP:0000709) | 2.21382606 |
| 78 | Abnormal pupillary function (HP:0007686) | 2.21312548 |
| 79 | Pancreatic fibrosis (HP:0100732) | 2.19875740 |
| 80 | Exotropia (HP:0000577) | 2.19618316 |
| 81 | Sleep apnea (HP:0010535) | 2.17728372 |
| 82 | Specific learning disability (HP:0001328) | 2.17696199 |
| 83 | Ulnar claw (HP:0001178) | 2.17145869 |
| 84 | Abnormal social behavior (HP:0012433) | 2.17086499 |
| 85 | Impaired social interactions (HP:0000735) | 2.17086499 |
| 86 | Narrow nasal bridge (HP:0000446) | 2.16006145 |
| 87 | Concave nail (HP:0001598) | 2.15697061 |
| 88 | Vaginal atresia (HP:0000148) | 2.13784016 |
| 89 | Retinal dysplasia (HP:0007973) | 2.13564955 |
| 90 | Abnormality of the labia minora (HP:0012880) | 2.13129672 |
| 91 | Abnormality of pain sensation (HP:0010832) | 2.10358456 |
| 92 | Impaired pain sensation (HP:0007328) | 2.10358456 |
| 93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.09800591 |
| 94 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.09708328 |
| 95 | Hypoplasia of the brainstem (HP:0002365) | 2.09708328 |
| 96 | Dysmetria (HP:0001310) | 2.09216005 |
| 97 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09093698 |
| 98 | Epileptiform EEG discharges (HP:0011182) | 2.08373528 |
| 99 | EEG with generalized epileptiform discharges (HP:0011198) | 2.08003153 |
| 100 | Inability to walk (HP:0002540) | 2.05967225 |
| 101 | Hemiparesis (HP:0001269) | 2.05387819 |
| 102 | Mitochondrial inheritance (HP:0001427) | 2.04761092 |
| 103 | Spastic gait (HP:0002064) | 2.04552440 |
| 104 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.04460201 |
| 105 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.04460201 |
| 106 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.01988084 |
| 107 | Absent/shortened dynein arms (HP:0200106) | 2.01988084 |
| 108 | Urinary urgency (HP:0000012) | 2.01460551 |
| 109 | Status epilepticus (HP:0002133) | 2.00359927 |
| 110 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.98800499 |
| 111 | Postural instability (HP:0002172) | 1.98012516 |
| 112 | Torticollis (HP:0000473) | 1.97591435 |
| 113 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.97298354 |
| 114 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.96668205 |
| 115 | Hypsarrhythmia (HP:0002521) | 1.96533040 |
| 116 | Abnormality of salivation (HP:0100755) | 1.95788378 |
| 117 | Bradykinesia (HP:0002067) | 1.94057685 |
| 118 | Absent speech (HP:0001344) | 1.92997603 |
| 119 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.92736335 |
| 120 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.91632713 |
| 121 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.91632713 |
| 122 | Anosmia (HP:0000458) | 1.90331107 |
| 123 | Fetal akinesia sequence (HP:0001989) | 1.89452489 |
| 124 | Intellectual disability, severe (HP:0010864) | 1.89013674 |
| 125 | Focal dystonia (HP:0004373) | 1.88985456 |
| 126 | Poor coordination (HP:0002370) | 1.88962214 |
| 127 | Delayed gross motor development (HP:0002194) | 1.86979694 |
| 128 | True hermaphroditism (HP:0010459) | 1.85938192 |
| 129 | Orthostatic hypotension (HP:0001278) | 1.85318783 |
| 130 | Akinesia (HP:0002304) | 1.83096466 |
| 131 | Gaze-evoked nystagmus (HP:0000640) | 1.82964992 |
| 132 | Dysdiadochokinesis (HP:0002075) | 1.82905839 |
| 133 | Long toe (HP:0010511) | 1.81664444 |
| 134 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80474024 |
| 135 | Prolonged QT interval (HP:0001657) | 1.80395225 |
| 136 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79696570 |
| 137 | Intention tremor (HP:0002080) | 1.79493311 |
| 138 | Pendular nystagmus (HP:0012043) | 1.78368734 |
| 139 | Chorioretinal coloboma (HP:0000567) | 1.75969623 |
| 140 | Cystic liver disease (HP:0006706) | 1.75015300 |
| 141 | Abnormal drinking behavior (HP:0030082) | 1.74203693 |
| 142 | Polydipsia (HP:0001959) | 1.74203693 |
| 143 | Hypoplasia of the corpus callosum (HP:0002079) | 1.74074587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.37623513 |
| 2 | MARK1 | 3.88040816 |
| 3 | MAP3K4 | 3.14699736 |
| 4 | MAP3K9 | 3.14581321 |
| 5 | MAP3K12 | 3.14095558 |
| 6 | PNCK | 2.90084058 |
| 7 | MAP2K7 | 2.69801316 |
| 8 | CASK | 2.67525149 |
| 9 | MINK1 | 2.62797169 |
| 10 | NTRK2 | 2.61071727 |
| 11 | NTRK1 | 2.58379463 |
| 12 | GRK5 | 2.17494004 |
| 13 | ARAF | 2.14374319 |
| 14 | STK38L | 2.13539236 |
| 15 | MAP2K4 | 2.07300764 |
| 16 | EPHA4 | 1.98870704 |
| 17 | PINK1 | 1.97501178 |
| 18 | LATS1 | 1.92073161 |
| 19 | MAPK13 | 1.92019423 |
| 20 | UHMK1 | 1.75590796 |
| 21 | FRK | 1.65099520 |
| 22 | GRK7 | 1.62557836 |
| 23 | TNIK | 1.57852075 |
| 24 | SIK2 | 1.45217098 |
| 25 | KSR2 | 1.35825779 |
| 26 | CDK5 | 1.35721409 |
| 27 | CSNK1G2 | 1.35686200 |
| 28 | PAK6 | 1.34013842 |
| 29 | PLK2 | 1.29587108 |
| 30 | DAPK2 | 1.26409419 |
| 31 | NME1 | 1.24369192 |
| 32 | PHKG1 | 1.20630837 |
| 33 | PHKG2 | 1.20630837 |
| 34 | CAMK2A | 1.20514317 |
| 35 | CSNK1G3 | 1.15728972 |
| 36 | PRKCG | 1.14831221 |
| 37 | KSR1 | 1.13785573 |
| 38 | LATS2 | 1.11922437 |
| 39 | MAPKAPK5 | 1.06783123 |
| 40 | TAOK1 | 1.06549785 |
| 41 | MAP3K11 | 1.05393787 |
| 42 | FES | 1.00747274 |
| 43 | SIK3 | 0.98902081 |
| 44 | MAP3K2 | 0.96152455 |
| 45 | ADRBK2 | 0.95046337 |
| 46 | ZAK | 0.94908612 |
| 47 | CAMK2B | 0.94209171 |
| 48 | PAK3 | 0.92640150 |
| 49 | CDK14 | 0.90868901 |
| 50 | ADRBK1 | 0.88427659 |
| 51 | CDK18 | 0.87837924 |
| 52 | DYRK1B | 0.87552576 |
| 53 | RIPK4 | 0.86968790 |
| 54 | BCR | 0.86356663 |
| 55 | WNK3 | 0.83968195 |
| 56 | CDK15 | 0.83398147 |
| 57 | PRKCE | 0.82341843 |
| 58 | STK38 | 0.82151993 |
| 59 | CDK19 | 0.79241625 |
| 60 | OXSR1 | 0.77588459 |
| 61 | RET | 0.75405846 |
| 62 | DYRK2 | 0.75008643 |
| 63 | BMPR1B | 0.74762838 |
| 64 | FGR | 0.74414917 |
| 65 | DAPK1 | 0.74227420 |
| 66 | SGK223 | 0.72797303 |
| 67 | SGK494 | 0.72797303 |
| 68 | CDK11A | 0.71108189 |
| 69 | PRKD3 | 0.70832308 |
| 70 | RPS6KA2 | 0.70625215 |
| 71 | STK11 | 0.70600395 |
| 72 | TYRO3 | 0.69443239 |
| 73 | PKN1 | 0.68515570 |
| 74 | CSNK1G1 | 0.68004070 |
| 75 | CAMK2D | 0.67699539 |
| 76 | CAMK2G | 0.66669712 |
| 77 | DYRK1A | 0.64845180 |
| 78 | LIMK1 | 0.64139941 |
| 79 | BRAF | 0.62766814 |
| 80 | STK39 | 0.59417796 |
| 81 | CAMKK1 | 0.58813890 |
| 82 | LMTK2 | 0.55873003 |
| 83 | MARK2 | 0.54846155 |
| 84 | CAMKK2 | 0.54570278 |
| 85 | WNK4 | 0.54351283 |
| 86 | SGK3 | 0.52738688 |
| 87 | IRAK2 | 0.52305825 |
| 88 | MAP3K1 | 0.51917045 |
| 89 | CAMK4 | 0.51155456 |
| 90 | TNK2 | 0.50963562 |
| 91 | PRPF4B | 0.50187583 |
| 92 | MAP2K1 | 0.49521823 |
| 93 | FER | 0.49146943 |
| 94 | PRKCZ | 0.48530900 |
| 95 | CAMK1G | 0.48200421 |
| 96 | MAPK15 | 0.48109546 |
| 97 | CAMK1 | 0.47352381 |
| 98 | MAPK12 | 0.47335256 |
| 99 | PRKCH | 0.47310559 |
| 100 | MATK | 0.45674411 |
| 101 | PRKACA | 0.45190869 |
| 102 | MAP3K6 | 0.43448169 |
| 103 | MUSK | 0.43141310 |
| 104 | TSSK6 | 0.42841413 |
| 105 | SGK2 | 0.42488647 |
| 106 | EPHB2 | 0.42157106 |
| 107 | MAP3K13 | 0.41007369 |
| 108 | AKT3 | 0.40998547 |
| 109 | CAMK1D | 0.40100437 |
| 110 | GRK1 | 0.39728483 |
| 111 | NEK2 | 0.38907800 |
| 112 | DYRK3 | 0.38703200 |
| 113 | GRK6 | 0.38558246 |
| 114 | PTK2B | 0.38273429 |
| 115 | PRKG1 | 0.38088608 |
| 116 | SGK1 | 0.38012107 |
| 117 | PRKCB | 0.37092549 |
| 118 | MARK3 | 0.36939470 |
| 119 | CSNK1A1L | 0.36385563 |
| 120 | EPHA3 | 0.35806842 |
| 121 | PRKCI | 0.34320511 |
| 122 | PRKAA1 | 0.33169530 |
| 123 | STK3 | 0.32204312 |
| 124 | WNK1 | 0.30958741 |
| 125 | PRKCQ | 0.30674957 |
| 126 | MAP2K2 | 0.27557031 |
| 127 | MAPK4 | 0.27108139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.81859707 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.44221875 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.76459137 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.61954493 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.58808199 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.49727636 |
| 7 | Cocaine addiction_Homo sapiens_hsa05030 | 2.39430891 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.38550578 |
| 9 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.34045226 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.33557803 |
| 11 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.29475138 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.26556982 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.23204815 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.20597869 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.17058607 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.15496105 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.10331984 |
| 18 | Long-term potentiation_Homo sapiens_hsa04720 | 2.07271575 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05387685 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.95708435 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89150411 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.86115327 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.74773263 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.72461435 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.68487615 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.63805381 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.62225064 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.60443304 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.50688686 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.46151456 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44046523 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36228141 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32791224 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.30931490 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28954353 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.26225680 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24458770 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.14923582 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08448321 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.01971061 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01716623 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.98915624 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97467078 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 0.96548421 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.91100920 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91085011 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89492377 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87485213 |
| 49 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86346438 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85311225 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82052530 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81988452 |
| 53 | Alcoholism_Homo sapiens_hsa05034 | 0.80497979 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79397498 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75467065 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73214958 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73138314 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73099581 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72794762 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72701543 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72023199 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71847731 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70067408 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69103117 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67975442 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67600820 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66874402 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64492700 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59816124 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.59390337 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59241513 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59238128 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58852291 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58024625 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.54541072 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54197216 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52642594 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52301923 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51727830 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51106925 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49904254 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49809852 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49258434 |
| 84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48680723 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48386689 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48150982 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.47211865 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46509980 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45551903 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.44947185 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44076527 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43704613 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42597697 |
| 94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41824831 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38519887 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38134184 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37453865 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36178066 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35449018 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35191796 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34855665 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34707343 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.34539310 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31911969 |
| 105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30868355 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30228654 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29630433 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29584670 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.26756972 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26012943 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25374167 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24917873 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24847646 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24700702 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24364010 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23095531 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22408179 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22081892 |
| 119 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.20791446 |
| 120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19719109 |

